Modeling alcohol reward and reinforcement in the human laboratory
Modeling alcohol reward and reinforcement in the human laboratory
批准号:
8924893
负责人:
LARA A. RAY
金额:
$17.74万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-10 至 2017-08-31
关键词:
Alcohol consumptionAlcohol dependenceAlcoholic beverage heavy drinkerAlcoholismAlcoholsAnimal ModelAnimalsCandidate Disease GeneChronicClinicalComputer AssistedConceptionsCorticotropin-Releasing HormoneDevelopmentDimensionsDiseaseDisease ProgressionEthanolEtiologyExhibitsFeelingGenesGenetic PolymorphismHealthHeavy DrinkingHumanIndividualInfusion proceduresIntakeLaboratoriesLaboratory StudyLiteratureMediatingMental disordersMethodologyMinisatellite RepeatsModelingMotivationNegative ReinforcementsNeurobiologyParticipantPatient Self-ReportPharmaceutical PreparationsPhenotypePopulationPositive ReinforcementsPrevalenceQuestionnairesRecruitment ActivityRelapseResearchResearch PersonnelRiskRoleSamplingScheduleSedation procedureSelf AdministrationSingle Nucleotide PolymorphismSystemTestingTheoretical modelTranslatingTranslationsWithdrawalWorkaddictionalcohol cravingalcohol cuealcohol effectalcohol reinforcementalcohol responsealcohol rewardalcohol use disorderbasebiobehaviorbreath alcohol measurementcompulsioncorticotropin releasing factor-binding proteincravingdesigndopamine transporterdrinkingindexingmu opioid receptorspre-clinicalpre-clinical researchreceptorresponsetheorieswillingness
中文摘要
描述(由申请人提供):酒精中毒病因学的动物和人类模型都集中在对酒精的生物行为反应上,作为酒精中毒风险脆弱性和疾病进展的潜在标志。在神经生物学模型中,酒精中毒被概念化为从正强化(即,“为了感觉良好而喝酒”)到负强化(即,“喝酒不是为了感觉不好或感觉正常”),代表了一个进行性神经生物学失调的循环。在人体实验室中进行的酒精给药研究通过检查不同饮酒状态水平(即重度饮酒或酒精依赖组)下对酒精的主观反应(包括刺激、镇静和缓解紧张维度),将临床前理论转化为临床人群。到目前为止,没有研究使用酒精管理范式翻译神经生物学模型的酒精中毒病因的临床人群。本申请的目的是在人类实验室研究酒精中毒病因学的成熟神经生物学理论。要做到这一点,本研究结合了传统的酒精挑战和渐进的比例自我管理的方法,以阐明主观反应酒精和一个人的意愿,为酒精工作之间的关系。为了模拟从积极到消极强化酒精使用的过渡,将招募两组(n总计= 82),
一组非依赖性重度饮酒者和一组酒精依赖者。一个探索性的目标将检查候选基因subserving积极和消极的酒精强化效果。拟议的研究扩展了酒精中毒文献,通过测试神经生物学知情的假设,饮酒状态对主观反应酒精在实验室中的调节作用和主观反应和自我管理额外的酒精自由之间的关系。
英文摘要
DESCRIPTION (provided by applicant): Both animal and human models of alcoholism etiology have focused on biobehavioral response to alcohol as a potential marker of alcoholism risk vulnerability and disease progression. Alcoholism has been conceptualized in neurobiological models as a transition from positive reinforcement (i.e., "drinking to feel good") to negative reinforcement (i.e., "drinking not to feel bad or to feel normal"), representing a cycl of progressive neurobiological dysregulation. Alcohol administration studies in the human laboratory allow for the translation of preclinical theory to clinical populations through examination of the subjective response to alcohol (comprising stimulation, sedation and tension relieving dimensions) at different levels of drinking status (i.e. heavy drinking or alcohol dependent groups). To date, no studies have used alcohol administration paradigms to translate neurobiological models of alcoholism etiology to clinical populations. The objective of this application is to examine well-established neurobiological theories of alcoholism etiology in the human laboratory. To do so this study combines traditional alcohol challenge and progressive ratio self-administration methodologies to elucidate the relationship between subjective response to alcohol and one's willingness to work for alcohol. In order to model the transition from positively to negatively reinforced alcohol use two groups (n total = 82) will be recruited, a
group of non- dependent heavy drinkers and a group of alcohol dependent individuals. An exploratory aim will examine candidate genes subserving the positive and negative reinforcing effects of alcohol. The proposed study extends the alcoholism literature through testing neurobiologically informed hypotheses about the moderating role of drinking status on subjective response to alcohol in the lab and the relationship between subjective response and self-administration of additional alcohol ad lib.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1080/00952990.2017.1312423
发表时间:
2017-01-01
期刊:
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
影响因子:
2.7
作者:
[Ray, Lara A., Bujarski, Spencer, Hartwell, Emily E.]
通讯作者:
Hartwell, Emily E.
An Exploratory Factor Analysis of the Stimulant, Sedative, and Affective Responses to Alcohol.
对酒精的兴奋、镇静和情感反应的探索性因素分析。
DOI:
10.1111/acer.14458
发表时间:
2020
期刊:
Alcoholism, clinical and experimental research
影响因子:
--
作者:
[Grodin,EricaN, Green,ReJoyce, Ray,LaraA]
通讯作者:
Ray,LaraA
The effects of stress on decision-making in alcohol use disorder: A translational approach
-
批准号:10667891
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2023
-
负责人:LARA A. RAY
-
依托单位:
Translational underpinnings of motivation for alcohol in humans
-
批准号:10345709
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2023
-
负责人:LARA A. RAY
-
依托单位:
Integrating findings across stages of medication development for AUD
-
批准号:10353926
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2021
-
负责人:LARA A. RAY
-
依托单位:
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
-
批准号:10387543
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2021
-
负责人:LARA A. RAY
-
依托单位:
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder
-
批准号:10387454
-
项目类别:
-
资助金额:$15.44万
-
财政年份:2021
-
负责人:LARA A. RAY
-
依托单位:
Integrating findings across stages of medication development for AUD
-
批准号:10491120
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2021
-
负责人:LARA A. RAY
-
依托单位:
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder
-
批准号:10019310
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2019
-
负责人:LARA A. RAY
-
依托单位:
A NOVEL HUMAN LABORATORY MODEL FOR SCREENING MEDICATIONS FOR ALCOHOL USE DISORDER
-
批准号:10095672
-
项目类别:
-
资助金额:$8.36万
-
财政年份:2019
-
负责人:LARA A. RAY
-
依托单位:
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder
-
批准号:9883692
-
项目类别:
-
资助金额:$66.22万
-
财政年份:2018
-
负责人:LARA A. RAY
-
依托单位:
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
-
批准号:10242146
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2018
-
负责人:LARA A. RAY
-
依托单位:
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials
-
批准号:10481839
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2018
-
负责人:LARA A. RAY
-
依托单位:
Combining varenicline and naltrexone for smoking cessation and drinking reduction
-
批准号:8913658
-
项目类别:
-
资助金额:$67.26万
-
财政年份:2015
-
负责人:LARA A. RAY
-
依托单位:
Combining varenicline and naltrexone for smoking cessation and drinking reduction
-
批准号:9285764
-
项目类别:
-
资助金额:$67.26万
-
财政年份:2015
-
负责人:LARA A. RAY
-
依托单位:
Modeling alcohol reward and reinforcement in the human laboratory
-
批准号:8773461
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2014
-
负责人:LARA A. RAY
-
依托单位:
Development of Ibudilast as a Novel Treatment for Alcoholism
-
批准号:8584224
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2013
-
负责人:LARA A. RAY
-
依托单位:
Development of Ibudilast as a Novel Treatment for Alcoholism
-
批准号:8699611
-
项目类别:
-
资助金额:$17.74万
-
财政年份:2013
-
负责人:LARA A. RAY
-
依托单位:
Optimizing naltrexone for individuals of East Asian descent
-
批准号:8725028
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2013
-
负责人:LARA A. RAY
-
依托单位:
Optimizing naltrexone for individuals of East Asian descent
-
批准号:8883102
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2013
-
负责人:LARA A. RAY
-
依托单位:
Optimizing naltrexone for individuals of East Asian descent
-
批准号:8579788
-
项目类别:
-
资助金额:$41.74万
-
财政年份:2013
-
负责人:LARA A. RAY
-
依托单位:
Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder
-
批准号:8656896
-
项目类别:
-
资助金额:$2.52万
-
财政年份:2011
-
负责人:LARA A. RAY
-
依托单位:
海外基金